Back to Research Hub
Sarepta Therapeutics, Inc.
SRPT
$15.89+0.34 (+2.19%)
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.
StreetsValue research for Sarepta Therapeutics, Inc. (SRPT)
Members get the full report for Sarepta Therapeutics, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.